BA CA - Silo Wellness CFO Director
| SILFFDelisted Stock | USD 0.01 0.00 0.00% |
Insider
BA CA is CFO Director of Silo Wellness
| Age | 57 |
| Phone | 416 861 2262 |
| Web | https://www.silowellness.com |
Silo Wellness Management Efficiency
The company has return on total asset (ROA) of (3.9555) % which means that it has lost $3.9555 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (4.3346) %, meaning that it generated substantial loss on money invested by shareholders. Silo Wellness' management efficiency ratios could be used to measure how well Silo Wellness manages its routine affairs as well as how well it operates its assets and liabilities.Silo Wellness has accumulated 2.17 M in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. Silo Wellness has a current ratio of 0.08, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Silo Wellness until it has trouble settling it off, either with new capital or with free cash flow. So, Silo Wellness' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Silo Wellness sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Silo to invest in growth at high rates of return. When we think about Silo Wellness' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| David Abitbol | Cannara Biotech | N/A | |
| Alexander Wolfe | Cannara Biotech | N/A | |
| Yosuke Akita | Eisai Co | 58 | |
| Kevin Pitts | Grey Cloak Tech | 63 | |
| France Landry | Cannara Biotech | N/A | |
| Brian Sherman | Cannara Biotech | N/A | |
| Julia Bouvet | Cannara Biotech | N/A | |
| Mba BEcon | Avicanna | N/A | |
| Etienne Ledoux | Cannara Biotech | N/A | |
| Carlos Muete | Avicanna | N/A | |
| Anthony Manouk | Cannara Biotech | N/A | |
| Scott Landers | Grey Cloak Tech | N/A | |
| Robert Madden | Grey Cloak Tech | 51 | |
| Caitlin Johnston | Avicanna | N/A | |
| Roland Alvarez | Avicanna | N/A | |
| Avi Krivorot | Cannara Biotech | N/A | |
| Frantz Devedec | Avicanna | N/A | |
| Teruyuki Masaka | Eisai Co | 45 | |
| Zohar Krivorot | Cannara Biotech | 46 | |
| Ivana Maric | Avicanna | N/A | |
| MD FAAN | Eisai Co | 73 | |
Management Performance
| Return On Equity | -4.33 | |||
| Return On Asset | -3.96 |
Silo Wellness Management Team
Elected by the shareholders, the Silo Wellness' board of directors comprises two types of representatives: Silo Wellness inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Silo. The board's role is to monitor Silo Wellness' management team and ensure that shareholders' interests are well served. Silo Wellness' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Silo Wellness' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mike Arnold, Interim Founder | ||
| Stuart Kirby, VP Communications | ||
| BA CA, CFO Director |
Silo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Silo Wellness a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -4.33 | |||
| Return On Asset | -3.96 | |||
| Operating Margin | (10.13) % | |||
| Current Valuation | 2.04 M | |||
| Shares Outstanding | 6.03 M | |||
| Shares Owned By Insiders | 1.34 % | |||
| Price To Sales | 0.17 X | |||
| Revenue | 120.12 K | |||
| Gross Profit | (268.49 K) | |||
| EBITDA | (6.09 M) |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Silo Pink Sheet
If you are still planning to invest in Silo Wellness check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Silo Wellness' history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |